$JNJ Recent News Timing this market is guaranteed to

New Post Public Reply Private Reply Replies (0) Message Board

Aug 17, 2014 at 10:31 AM

$JNJ Recent News

Timing this market is guaranteed to make you a loser 1:02 p.m. Aug. 8, 2014 - Mark Hulbert
You don’t have to be a mega-mind to get this trade right 7:54 a.m. Aug. 6, 2014 - Jim Lowell
Mega caps with mega recommendations 7:54 a.m. Aug. 6, 2014 - Mark Hulbert
These eight health-care stocks could rise up to 75% 1:48 p.m. Aug. 5, 2014 - Philip van Doorn
J&J to call for voluntary return of morcellators 5:30 p.m. July 30, 2014 - MarketWatch.com
Chipotle tops S&P 500, Herbalife ignores ‘death blow’ 1:14 p.m. July 22, 2014 - MarketWatch
Johnson & Johnson sets $5 billion share buyback 5:20 p.m. July 21, 2014 - Jim Jelter
Two rules of thumb for dumping your financial adviser 2:36 p.m. July 18, 2014 - Mark Hulbert
Dow ekes out a gain, but S&P falls; Yellen knocks biotechs and social media: live blog recap 3:04 p.m. July 15, 2014 - blogs.marketwatch.com
Johnson & Johnson shares dip on cautious outlook 10:55 a.m. July 15, 2014 - blogs.marketwatch.com
Plug Power rallies; Lorillard drops on Reynolds merger 10:40 a.m. July 15, 2014 - Angela Johnson
Newscast: NBA wants to double TV fees 9:59 a.m. July 15, 2014 - MarketWatch
Johnson & Johnson tops forecasts, boosts outlook 7:57 a.m. July 15, 2014 - MarketWatch.com
Johnson & Johnson shares up 0.4% in premarket trade 7:51 a.m. July 15, 2014 - Tomi Kilgore
Johnson & Johnson sees full-year 2014 adjusted EPS of $5.85 to $5.92 7:50 a.m. July 15, 2014 - William L. Watts
Johnson & Johnson Q2 sales up 9.1% to $19.5 billion 7:49 a.m. July 15, 2014 - William L. Watts
Johnson & Johnson Q2 adjusted EPS $1.66 7:49 a.m. July 15, 2014 - William L. Watts
Johnson & Johnson Q2 EPS $1.51 vs. $1.33 a year earlier 7:47 a.m. July 15, 2014 - William L. Watts
The market in a minute: Earnings over politics 10:56 a.m. July 14, 2014 - The Trading Deck
Tech, bank earnings to test economic recovery 6:01 a.m. July 13, 2014 - Wallace Witkowski

Retirement Strategy: How Dividend Income Grows To Staggering Levels By Reinvesting And Compounding 7:27 a.m. Today - Seeking Alpha
Tracking Warren Buffett's Berkshire Hathaway Portfolio - Q2 2014 Update 5:19 a.m. Aug. 16, 2014 - Seeking Alpha
Interpublic Working With Banks on Reply to Elliott 6:57 p.m. Aug. 15, 2014 - The Wall Street Journal Interactive Edition
The 4 Stocks That Weighed on the Market 3:27 p.m. Aug. 15, 2014 - 247WallSt.com
A Few Reasons Why Investors Should Consider Dendreon for Their Portfolio 11:18 a.m. Aug. 15, 2014 - GuruFocus.com
Invest in Dividend Stocks for Retirement Planning 5:30 a.m. Aug. 15, 2014 - InvestorPlace.com
Tracking Tweedy Browne Portfolio - Q2 2014 Update 12:15 a.m. Aug. 15, 2014 - Seeking Alpha
How To Weight Your Dividend Growth Stocks 11:27 p.m. Aug. 14, 2014 - Seeking Alpha
Major Portfolio Changes for Warren Buffett and Berkshire Hathaway 4:40 p.m. Aug. 14, 2014 - 247WallSt.com
2 Key Tests For The True Dividend Growth Investor 2:44 p.m. Aug. 14, 2014 - Seeking Alpha
Tracking Prem Watsa's Fairfax Financial Holdings Portfolio - Q2 2014 Update 6:00 a.m. Aug. 14, 2014 - Seeking Alpha
Constructing A Monthly Income Portfolio 6:50 p.m. Aug. 13, 2014 - Seeking Alpha
Dow Today: Johnson & Johnson (JNJ) Leads The Day Higher, Goldman Sachs Group (GS) Lags 10:00 a.m. Aug. 13, 2014 - TheStreet.com
The Most Important Financial Statement When Selecting Dividend Growth Stocks 9:31 p.m. Aug. 12, 2014 - Seeking Alpha
Dow Today: E I Du Pont De Nemours & Company (DD) Leads The Day Higher, Johnson & Johnson (JNJ) Lags 4:30 p.m. Aug. 12, 2014 - TheStreet.com
The Comfort In Watching Coca-Cola Decline 25% 3:55 p.m. Aug. 12, 2014 - Seeking Alpha
10-Q: GREATBATCH, INC. 2:53 p.m. Aug. 12, 2014 - Edgar Online - (EDG = 10Q, 10K)
Intercept Pharma Soars On Liver-Disease Drug Data 9:48 a.m. Aug. 12, 2014 - Investors Business Daily
'Fast Money' Recap: Can You Trust This Rally? 5:00 a.m. Aug. 12, 2014 - TheStreet.com
Retirement Strategy: The Absurdity Of Believing That Dividends Don't Matter In Retirement 9:10 p.m. Aug. 11, 2014 - Seeking Alpha

Lawsuit Settlement News Website Reports Update on Risperdal Litigation Due to Increase of Filed Cases 5:00 a.m. Aug. 15, 2014 - PR Newswire - PRF
Global Antiseptic and Disinfectant Products Market 2014-2018 11:21 a.m. Aug. 13, 2014 - PR Newswire - PRF
Can We Change the Culture of Youth Sports? 7:00 a.m. Aug. 13, 2014 - PR Newswire - PRF
Entia Biosciences' Supplements Could Prevent Dementia 9:55 a.m. Aug. 12, 2014 - ACCESSWIRE
David Defeats Goliath (Again), DECN and Pharma Tech Solutions Awarded Victory Over Johnson & Johnson Lifescan in USPTO Final Ruling 9:20 a.m. Aug. 11, 2014 - Marketwire
Product Launch, Technical Updates, Clinical Study Results, Completion of Tender Offer, and Financial Result - Research Reports on Medtronic, Covidien, Johnson & Johnson, Merck and Jazz 9:20 a.m. Aug. 11, 2014 - PR Newswire - PRF
Anapol Schwartz Law Firm Accepting Morcellation Cancer Cases 2:05 p.m. Aug. 8, 2014 - Marketwire
DePuy ASR Hip Settlement Funding Begins to Wind Down, Says Legal-Bay Lawsuit Funding 5:00 a.m. Aug. 7, 2014 - PR Newswire - PRF
Johnson & Johnson app makes it a snap to help students with United Way 9:45 a.m. Aug. 6, 2014 - PR Newswire - PRF
Drug Approvals and Earnings Releases - Research Reports on Bristol-Myers, Johnson & Johnson, Merck, Pharmacyclics and Amgen 8:50 a.m. Aug. 4, 2014 - PR Newswire - PRF
CircleUp Announces Collaboration with Johnson & Johnson Innovation to Identify Transformative Consumer Companies 7:30 a.m. July 31, 2014 - Marketwire
Dendreon Names W. Thomas Amick President and Chief Executive Officer 4:04 p.m. July 30, 2014 - BusinessWire - BZX
Milestone Scientific Appoints Senior Healthcare Industry Executive Steven F. Robins as Marketing Consultant 7:32 a.m. July 30, 2014 - Marketwire
IBM Elects Two New Members to Its Board of Directors 4:34 p.m. July 29, 2014 - BusinessWire - BZX
Accelerator Corporation Secures $51.1 Million to Support Emerging Biotechnology Research Opportunities in New York City and Seattle 7:00 a.m. July 29, 2014 - BusinessWire - BZX
Global Aortic Stent Grafts Market 2014-2018 6:24 p.m. July 28, 2014 - PR Newswire - PRF
Global Non-Hodgkin Lymphoma Therapeutics Market 2014-2018 4:00 p.m. July 28, 2014 - PR Newswire - PRF
Decision Lens Secures $6.5 Million in Funding to Continue Record-Breaking Growth 12:21 p.m. July 24, 2014 - Marketwire
Abdominal Obesity Global Clinical Trials Review, H1, 2014 4:42 p.m. July 23, 2014 - PR Newswire - PRF
Global Markets for Catheters 3:21 p.m. July 23, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

USD 6.8 Million for Disease R&D: GHIT's Bold Bet

GHIT Fund Pumps Millions Into Health R&D In a world plagued by infectious disease outbreaks and continual health challenges, the Global Health Innovative Technology (GHIT) Fund isn't just twiddling its thumbs—they're throwing down around $6.8 million to wrestle some of the nastiest bugs out there, like malaria and Ebola. This cash doubles down on nine risky gambles,...

Oracle's Bold Vision: Targeting $225B Revenue by 2030

Oracle Lays Down a Bold Gauntlet Oracle Corporation (NYSE: ORCL) sure knows how to draw the spotlight. With their recent Investor Day in Vegas, they've laid out ambitions that could make even the most seasoned Wall Streeter spit out their coffee. Who would've thought they'd be betting on a whopping $225 billion in revenue by FY30? That's supposed to be a more than 35%...

Coffee Bean Brews Up Nostalgia with Tiramisu Treats

Pouring Old Favorites: The Tiramisu Return When the aromas of coffee and nostalgia waft through the air, it's often a sign that The Coffee Bean & Tea Leaf® is brewing something special. This year, they've decided to double down on the holiday cheer by reintroducing their wildly popular Tiramisu beverage. This ain't just your run-of-the-mill coffee drink—it's a full-on...

EQS Group Unveils 'Q': AI-Driven Compliance Revolution

Compliance in the Fast Lane The compliance world just got a hefty upgrade with EQS Group's latest rollout: 'Q by EQS,' an AI-powered intelligence layer that's here to shake up the way compliance tasks are handled. It's integrated right into the heart of the EQS Compliance Cockpit, giving teams an edge by automating those pesky, time-sucking routines and guiding them...

Liberty Systems Expands Operations with Major HQ Move

Hardly a yawn-worthy move, folks. Liberty Systems up and switched from Waukesha to Oconomowoc, boosting its digs to a sprawling 100,000-square-foot headquarters. It's a classic tale of growth for the Wisconsin-based company known for its on-site nitrogen generators and compressed air systems. Now, I'm telling you, they've more than doubled production capacity—that's a...

Bank Leumi Q3 Earnings Preview: Key Dates & Insights

A Closer Look at Bank Leumi's Upcoming Q3 Release Take a seat, folks. Bank Leumi’s gearing up to spill the beans on their Third Quarter 2026 earnings come November 17th. If you’re in the financial world, you might want to mark your calendar because these reports tend to shake things up. You know how these go - numbers rolling out, market responses, and plenty of...

Doximity Faces Legal Heat: 23% Stock Plunge Analyzed

Doximity's Rollercoaster: Steep Drop Amid Lawsuits Imagine watching your portfolio take a gut-wrenching plunge—and that's the rollercoaster ride Doximity investors experienced. On May 14, 2026, Doximity's stock nosedived by 23%, closing at $18.01 per share. This tumble, which marked a painful conclusion to a series of financial disappointments, has thrown the company...

Data Breach at Lumara Bio: Privacy Lawsuits Loom

Another Day, Another Data Breach It seems like you can’t throw a stone without hitting a data breach these days—and this time, it’s Lumara Bio USA’s turn under the spotlight. The Princeton-based oncology therapeutics outfit, part of Germany’s ITM Isotope Technologies, spilled some beans it never meant to. We're talking some pretty sensitive stuff here, folks....

Wendy's Faces Takeover Bid Amid Strategic Focus Shift

Behind the Unsolicited Offer Folks, it looks like Wendy's (NASDAQ:WEN) got itself mixed up in some high-stakes shenanigans. An unsolicited, non-binding proposal slammed into them, courtesy of the Investor Group led by Trian Partners, Flynn Group LP, BlueFive Capital, and Sixth Street Partners, itching to scoop up every last piece of Wendy’s stock they ain't already...

Custom Homes Shine: Florida’s Lucrative Property Move

Why Custom Homes Are Worth the Investment in Florida Ever thought about sinking some cash into Florida's real estate game? Well, building a custom home might just be your golden ticket, according to Paul H Schaefer II from Sage Homes LLC. I mean, everyone knows Florida's housing market is as spicy as a chili pepper, but custom homes seem to be the secret sauce here....